Figure 2From: Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in transgenic mouse models of frontotemporal lobar degeneration and Alzheimer’s diseaseEffect of 17-AAG on amyloid plaques in Tg2576 mice. Thioflavin S staining of amyloid plaques (green) in the hippocampus of Tg2576 mice treated with different doses of 17-AAG: A) 0 mg/kg (Control), B) 5 mg/kg, C) 25 mg/kg. Four fields of each dose are shown.Back to article page